OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy of Immune Checkpoint Inhibition and Cytotoxic Chemotherapy in Mismatch Repair-Deficient and Microsatellite Instability-High Pancreatic Cancer: Mayo Clinic Experience
Tucker Coston, Aakash Desai, Hani M. Babiker, et al.
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 23
Tucker Coston, Aakash Desai, Hani M. Babiker, et al.
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 23
Showing 23 citing articles:
Near-infrared Photoimmunotherapy: mechanisms, applications, and future perspectives in cancer research
Donald O. Allen, Madeline JoAnna Szoo, Tessa D. van Bergen, et al.
Antibody Therapeutics (2025) Vol. 8, Iss. 1, pp. 68-85
Open Access | Times Cited: 1
Donald O. Allen, Madeline JoAnna Szoo, Tessa D. van Bergen, et al.
Antibody Therapeutics (2025) Vol. 8, Iss. 1, pp. 68-85
Open Access | Times Cited: 1
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer
Catherine O’Connor, Emily Harrold, David Lin, et al.
JAMA Oncology (2024)
Closed Access | Times Cited: 5
Catherine O’Connor, Emily Harrold, David Lin, et al.
JAMA Oncology (2024)
Closed Access | Times Cited: 5
Pancreatic Ductal Adenocarcinoma with Medullary Features and a Complete Pathological Response After Neoadjuvant FOLFIRINOX: A Case Report and Literature Review
Rodrigo G. Taboada, Maria Fernanda Arruda Almeida, Karina Miranda Santiago, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Rodrigo G. Taboada, Maria Fernanda Arruda Almeida, Karina Miranda Santiago, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Current status of cancer genome medicine for pancreatic ductal adenocarcinoma
Toshifumi Doi, Takeshi Ishikawa, Michihisa Moriguchi, et al.
Japanese Journal of Clinical Oncology (2025)
Closed Access
Toshifumi Doi, Takeshi Ishikawa, Michihisa Moriguchi, et al.
Japanese Journal of Clinical Oncology (2025)
Closed Access
Advances in Vaccine-Based Therapies for Pancreatic Cancer
Matthew T. McMillan, Kevin C. Soares
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Open Access
Matthew T. McMillan, Kevin C. Soares
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Open Access
Pancreatic Ductal Adenocarcinoma (PDAC): Clinical Progress in the Last Five Years
Osama Mosalem, Ahmed Abdelhakeem, Nayef Hikmat Abdel-Razeq, et al.
Expert Opinion on Investigational Drugs (2025), pp. 1-12
Closed Access
Osama Mosalem, Ahmed Abdelhakeem, Nayef Hikmat Abdel-Razeq, et al.
Expert Opinion on Investigational Drugs (2025), pp. 1-12
Closed Access
Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123)
David P. Witte, Ina Pretzell, Timm M. Reißig, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 10
Open Access | Times Cited: 3
David P. Witte, Ina Pretzell, Timm M. Reißig, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 10
Open Access | Times Cited: 3
Novel Therapies for Pancreatic Cancer
Victoria Chung, Jonathan D. Mizrahi, Shubham Pant
JCO Oncology Practice (2024)
Closed Access | Times Cited: 3
Victoria Chung, Jonathan D. Mizrahi, Shubham Pant
JCO Oncology Practice (2024)
Closed Access | Times Cited: 3
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
Margherita Ambrosini, Paolo Manca, Vincenzo Nasca, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access
Margherita Ambrosini, Paolo Manca, Vincenzo Nasca, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access
Pancreatic cancer
Thomas F. Stoop, Ammar A. Javed, Atsushi Oba, et al.
The Lancet (2025) Vol. 405, Iss. 10485, pp. 1182-1202
Closed Access
Thomas F. Stoop, Ammar A. Javed, Atsushi Oba, et al.
The Lancet (2025) Vol. 405, Iss. 10485, pp. 1182-1202
Closed Access
Improving outcomes of patients with pancreatic cancer
Stephan Dreyer, Philip Beer, Sunil R. Hingorani, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access
Stephan Dreyer, Philip Beer, Sunil R. Hingorani, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access
Case report: Microsatellite instability-high pancreas adenosquamous carcinoma with postoperative liver metastasis recurrence treated with multimodality therapy achieving complete pathological response
Qinghua Liu, Ruoyun Li, Wei Zhu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Qinghua Liu, Ruoyun Li, Wei Zhu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer
Himil Mahadevia, Pedro Luiz Serrano Usón, Jing Wang, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 1, pp. 79-90
Closed Access | Times Cited: 2
Himil Mahadevia, Pedro Luiz Serrano Usón, Jing Wang, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 1, pp. 79-90
Closed Access | Times Cited: 2
Upper Gastrointestinal Cancers and the Role of Genetic Testing
Emily Harrold, Zsofia K. Stadler
Hematology/Oncology Clinics of North America (2024) Vol. 38, Iss. 3, pp. 677-691
Closed Access | Times Cited: 2
Emily Harrold, Zsofia K. Stadler
Hematology/Oncology Clinics of North America (2024) Vol. 38, Iss. 3, pp. 677-691
Closed Access | Times Cited: 2
Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series
Maahum Mehdi, Aniko Szabo, Aditya Shreenivas, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 2
Maahum Mehdi, Aniko Szabo, Aditya Shreenivas, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 2
Identifying Actionable Alterations in KRAS Wild-Type Pancreatic Cancer
Ahmed Elhariri, Jaydeepbhai Patel, Himil Mahadevia, et al.
Targeted Oncology (2024) Vol. 19, Iss. 5, pp. 679-689
Closed Access | Times Cited: 1
Ahmed Elhariri, Jaydeepbhai Patel, Himil Mahadevia, et al.
Targeted Oncology (2024) Vol. 19, Iss. 5, pp. 679-689
Closed Access | Times Cited: 1
Redefining pancreatic cancer management with tumor-agnostic precision medicine
Neha K. Reddy, Vivek Subbiah
Carcinogenesis (2024) Vol. 45, Iss. 11, pp. 836-844
Closed Access | Times Cited: 1
Neha K. Reddy, Vivek Subbiah
Carcinogenesis (2024) Vol. 45, Iss. 11, pp. 836-844
Closed Access | Times Cited: 1
Complete pathological response to pembrolizumab in pretreated pancreatic acinar cell carcinoma
Valeria Merz, Francesca Maines, Stefano Marcucci, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 7
Open Access | Times Cited: 1
Valeria Merz, Francesca Maines, Stefano Marcucci, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 7
Open Access | Times Cited: 1
A narrative review on rare types of pancreatic cancer: should they be treated as pancreatic ductal adenocarcinomas?
Victor Hugo Fonseca de Jesus, Mauro Daniel Spina Donadio, Angelo Borsarelli Carvalho Brito, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
Victor Hugo Fonseca de Jesus, Mauro Daniel Spina Donadio, Angelo Borsarelli Carvalho Brito, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials
Robin John Lester Imperial, Osama Mosalem, Umair Majeed, et al.
Clinical and Experimental Gastroenterology (2024) Vol. Volume 17, pp. 121-134
Open Access
Robin John Lester Imperial, Osama Mosalem, Umair Majeed, et al.
Clinical and Experimental Gastroenterology (2024) Vol. Volume 17, pp. 121-134
Open Access
Molecular testing for personalized therapy is underutilized in patients with borderline resectable and locally advanced pancreatic cancer – real world data from the NORPACT-2 study
Ingvild Farnes, Marius Lund‐Iversen, Lars Aabakken, et al.
Scandinavian Journal of Gastroenterology (2024) Vol. 59, Iss. 9, pp. 1093-1096
Open Access
Ingvild Farnes, Marius Lund‐Iversen, Lars Aabakken, et al.
Scandinavian Journal of Gastroenterology (2024) Vol. 59, Iss. 9, pp. 1093-1096
Open Access
Salvage Surgery for Unifocal Progressive Metastatic Mismatch Repair–Deficient GI Cancer Responding to Immune Checkpoint Inhibition
Pieterjan Perremans, Filip Van Herpe, Gertjan Rasschaert, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access
Pieterjan Perremans, Filip Van Herpe, Gertjan Rasschaert, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access
Assessing Influence of Mismatch Repair Mutations on Survival in Patients After Resection of Pancreatic Ductal and Periampullary Adenocarcinoma
Elizabeth Prezioso, Eleanor Mancheski, Kylee Shivok, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 20, pp. 6185-6185
Open Access
Elizabeth Prezioso, Eleanor Mancheski, Kylee Shivok, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 20, pp. 6185-6185
Open Access
The Road to Overcome Pancreatic Cancer: Where Are We?
Alexandru Tirpe, Cristian Streianu, Ekaterina Isachesku, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38196-e38196
Open Access
Alexandru Tirpe, Cristian Streianu, Ekaterina Isachesku, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38196-e38196
Open Access
